Search Results
Insights into the treatment of patients with FLT3-mutated AML & the role of maintenance therapy
The management of R/R FLT3-mutated AML
Gilteritinib maintenance after allogeneic transplantation in FLT3-mutated AML
New Findings and Improved Outcomes in the Treatment of AML
Insights into the future of AML therapy: the increasing use of targeted agents
FLT3 inhibitors – an ideal strategy for treating FLT3-mutated AML
FLT3-Mutated AML: Early Aggressive Therapy vs Transplant
An insight into MRD monitoring and MRD-driven treatment in AML
Optimizing the use of FLT3 inhibitors in AML: sequencing, post-transplant maintenance & more
Maintenance therapy in AML: agents under investigation and future outlooks
FLT3 inhibitors as maintenance therapy in AML
Insights into several sub-studies of the QuANTUM-First trial of quizartinib in FLT3-ITD+ AML
